According to Zen Score, the 3 best drug store stocks to buy right now are:
1. Petmed Express (NASDAQ:PETS)
Petmed Express (NASDAQ:PETS) is the top pharmaceutical retailer stock with a Zen Score of 26, which is 7 points higher than the pharmaceutical retailer industry average of 19. It passed 10 out of 38 due diligence checks and has average fundamentals. Petmed Express has seen its stock lose -70.1% over the past year, underperforming other pharmaceutical retailer stocks by -18 percentage points.
Petmed Express has an average 1 year
price target of $6.50, an upside of 43.49% from Petmed Express's current stock price of $4.53.
Petmed Express stock has a consensus Strong Sell recommendation according to Wall Street analysts. Of the 1 analyst covering Petmed Express, 0% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 100% have issued a Strong Sell.
2. High Tide (NASDAQ:HITI)
High Tide (NASDAQ:HITI) is the second best pharmaceutical retailer stock with a Zen Score of 25, which is 6 points higher than the pharmaceutical retailer industry average of 19. It passed 8 out of 33 due diligence checks and has weak fundamentals. High Tide has seen its stock return 81.06% over the past year, overperforming other pharmaceutical retailer stocks by 134 percentage points.
High Tide has an average 1 year
price target of $4.50, an upside of 88.28% from High Tide's current stock price of $2.39.
High Tide stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering High Tide, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
3. Sunlink Health Systems (NYSEMKT:SSY)
Sunlink Health Systems (NYSEMKT:SSY) is the third best pharmaceutical retailer stock with a Zen Score of 24, which is 5 points higher than the pharmaceutical retailer industry average of 19. It passed 7 out of 33 due diligence checks and has weak fundamentals. Sunlink Health Systems has seen its stock lose -35.05% over the past year, overperforming other pharmaceutical retailer stocks by 17 percentage points.